{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:32:47Z","timestamp":1774517567049,"version":"3.50.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000051","name":"NHGRI","doi-asserted-by":"publisher","award":["SAC160070"],"award-info":[{"award-number":["SAC160070"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"NHGRI","doi-asserted-by":"publisher","award":["U01 HG007253"],"award-info":[{"award-number":["U01 HG007253"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GE Healthymagination award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>As clinical trials evolve in complexity, clinical trial data models that can capture relevant trial data in meaningful, structured annotations and computable forms are needed to support accrual.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Material and Methods<\/jats:title>\n                  <jats:p>We have developed a clinical trial information model, curation information system, and a standard operating procedure for consistent and accurate annotation of cancer clinical trials. Clinical trial documents are pulled into the curation system from publicly available sources. Using a web-based interface, a curator creates structured assertions related to disease-biomarker eligibility criteria, therapeutic context, and treatment cohorts by leveraging our data model features. These structured assertions are published on the My Cancer Genome (MCG) website.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>To date, over 5000 oncology trials have been manually curated. All trial assertion data are available for public view on the MCG website. Querying our structured knowledge base, we performed a landscape analysis to assess the top diseases, biomarker alterations, and drugs featured across all cancer trials.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Beyond curating commonly captured elements, such as disease and biomarker eligibility criteria, we have expanded our model to support the curation of trial interventions and therapeutic context (ie, neoadjuvant, metastatic, etc.), and the respective biomarker-disease treatment cohorts. To the best of our knowledge, this is the first effort to capture these fields in a structured format.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This paper makes a significant contribution to the field of biomedical informatics and knowledge dissemination for precision oncology via the MCG website.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key words<\/jats:title>\n                  <jats:p>knowledge representation, My Cancer Genome, precision oncology, knowledge curation, cancer informatics, clinical trial data model<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jamia\/ocaa066","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T04:18:06Z","timestamp":1587183486000},"page":"1057-1066","source":"Crossref","is-referenced-by-count":16,"title":["The My Cancer Genome clinical trial data model and trial curation workflow"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0168-7874","authenticated-orcid":false,"given":"Neha","family":"Jain","sequence":"first","affiliation":[{"name":"Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}]},{"given":"Kathleen F","family":"Mittendorf","sequence":"additional","affiliation":[{"name":"Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}]},{"given":"Marilyn","family":"Holt","sequence":"additional","affiliation":[{"name":"Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}]},{"given":"Michele","family":"Lenoue-Newton","sequence":"additional","affiliation":[{"name":"Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}]},{"given":"Ian","family":"Maurer","sequence":"additional","affiliation":[{"name":"GenomOncology LLC, Cleveland, Ohio, USA"}]},{"given":"Clinton","family":"Miller","sequence":"additional","affiliation":[{"name":"GenomOncology LLC, Cleveland, Ohio, USA"}]},{"given":"Matthew","family":"Stachowiak","sequence":"additional","affiliation":[{"name":"GenomOncology LLC, Cleveland, Ohio, USA"}]},{"given":"Michelle","family":"Botyrius","sequence":"additional","affiliation":[{"name":"GenomOncology LLC, Cleveland, Ohio, USA"}]},{"given":"James","family":"Cole","sequence":"additional","affiliation":[{"name":"GenomOncology LLC, Cleveland, Ohio, USA"}]},{"given":"Christine","family":"Micheel","sequence":"additional","affiliation":[{"name":"Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA"},{"name":"Department of Medicine, Division of Hematology\/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}]},{"given":"Mia","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, Rush University Medical Center, Chicago, Illinois, USA"},{"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}]}],"member":"286","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"issue":"36","key":"2020110613084152300_ocaa066-B1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/EDBK_156686","article-title":"The role of clinical trial participation in cancer research: barriers, evidence, and strategies","volume":"36","author":"Unger","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"5","key":"2020110613084152300_ocaa066-B2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ctrv.2015.02.009","article-title":"The landscape of precision cancer medicine clinical trials in the United States","volume":"41","author":"Roper","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"2020110613084152300_ocaa066-B3","year":"2019"},{"issue":"7","key":"2020110613084152300_ocaa066-B4","doi-asserted-by":"crossref","first-page":"djv193","DOI":"10.1093\/jnci\/djv193","article-title":"NCI-MATCH launch highlights new trial design in precision-medicine era","volume":"107","author":"McNeil","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2020110613084152300_ocaa066-B5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2014.59.8433","article-title":"Basket trials and the evolution of clinical trial design in an era of genomic medicine","volume":"33","author":"Redig","year":"2015","journal-title":"J Clin Oncol"},{"key":"2020110613084152300_ocaa066-B6","first-page":"487","article-title":"Semi-automatically inducing semantic classes of clinical research eligibility criteria using UMLS and hierarchical clustering","author":"Luo","year":"2010","journal-title":"AMIA Ann Symp Proc 2010;"},{"issue":"1","key":"2020110613084152300_ocaa066-B7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jbi.2012.07.006","article-title":"A human\u2013computer collaborative approach to identifying common data elements in clinical trial eligibility criteria","volume":"46","author":"Luo","year":"2013","journal-title":"J Biomed Inform"},{"key":"2020110613084152300_ocaa066-B8","first-page":"126","article-title":"Adapting a natural language processing tool to facilitate clinical trial curation for personalized cancer therapy","author":"Zeng","year":"2014","journal-title":"AMIA Joint Summits Translational Science Proceedings"},{"issue":"4","key":"2020110613084152300_ocaa066-B9","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/jamia\/ocw009","article-title":"Extracting genetic alteration information for personalized cancer therapy from ClinicalTrials","volume":"23","author":"Xu","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"2020110613084152300_ocaa066-B10","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1186\/1471-2164-13-S8-S21","article-title":"Identifying the status of genetic lesions in cancer clinical trial documents using machine learning","volume":"13 (Suppl 8","author":"Wu","year":"2012","journal-title":"BMC Genomics"},{"key":"2020110613084152300_ocaa066-B11","author":"Lindsay","year":"2017"},{"key":"2020110613084152300_ocaa066-B12","doi-asserted-by":"crossref","first-page":"CIN.S19454","DOI":"10.4137\/CIN.S19454","article-title":"Trial prospector: matching patients with cancer research studies using an automated and scalable approach","volume":"13","author":"Sahoo","year":"2014","journal-title":"Cancer Inform"},{"key":"2020110613084152300_ocaa066-B13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40246-016-0061-7","article-title":"The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies","volume":"10","author":"Patterson","year":"2016","journal-title":"Hum Genomics"},{"issue":"11","key":"2020110613084152300_ocaa066-B14","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1101\/gr.131128.111","article-title":"Translating genomic information into clinical medicine: lung cancer as a paradigm","volume":"22","author":"Levy","year":"2012","journal-title":"Genome Res"},{"key":"2020110613084152300_ocaa066-B15","first-page":"878","article-title":"Evaluating an NLP-based approach to modeling computable clinical trial eligibility criteria","volume":"2007","author":"Borlawsky","year":"2007","journal-title":"AMIA Ann Symp Proc"},{"key":"2020110613084152300_ocaa066-B16","first-page":"853","article-title":"Analysis of eligibility criteria from ClinicalTrials.Gov","volume":"205","author":"Doods","year":"2014","journal-title":"Stud Health Technol Inform"},{"key":"2020110613084152300_ocaa066-B17","first-page":"687","article-title":"Initial readability assessment of clinical trial eligibility criteria","volume":"2015","author":"Kang","year":"2015","journal-title":"AMIA Ann Symp Proc"},{"key":"2020110613084152300_ocaa066-B18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12911-015-0149-3","article-title":"Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients","volume":"15","author":"Ni","year":"2015","journal-title":"BMC Med Inform Decis Mak"},{"issue":"10","key":"2020110613084152300_ocaa066-B19","doi-asserted-by":"crossref","first-page":"e111055","DOI":"10.1371\/journal.pone.0111055","article-title":"ClinicalTrials.Gov as a data source for semi-automated point-of-care trial eligibility screening","volume":"9","author":"Pfiffner","year":"2014","journal-title":"PLoS One"},{"key":"2020110613084152300_ocaa066-B20","first-page":"46","article-title":"Analysis of eligibility criteria complexity in clinical trials","volume":"2010","author":"Ross","year":"2010","journal-title":"Summit Transl Bioinform"},{"key":"2020110613084152300_ocaa066-B21","year":"2019"},{"key":"2020110613084152300_ocaa066-B22","year":"2019"},{"key":"2020110613084152300_ocaa066-B23","year":"2019"},{"key":"2020110613084152300_ocaa066-B24"},{"key":"2020110613084152300_ocaa066-B25","year":"2019"},{"key":"2020110613084152300_ocaa066-B26","article-title":"Revised WHO classification of hematologic malignancies","volume":"2016","author":"Williams","year":"2016","journal-title":"NEJM J. Watch"},{"key":"2020110613084152300_ocaa066-B27","year":"2019"},{"key":"2020110613084152300_ocaa066-B28","year":"2019"},{"key":"2020110613084152300_ocaa066-B29","year":"2019"},{"key":"2020110613084152300_ocaa066-B30","year":"2019"},{"key":"2020110613084152300_ocaa066-B31","year":"2019"},{"key":"2020110613084152300_ocaa066-B32","year":"2019"},{"key":"2020110613084152300_ocaa066-B33","year":"2019"},{"key":"2020110613084152300_ocaa066-B34","year":"2019"},{"key":"2020110613084152300_ocaa066-B35","year":"2019"},{"issue":"D1","key":"2020110613084152300_ocaa066-B36","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the drugbank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2020110613084152300_ocaa066-B37","year":"2019"},{"issue":"3","key":"2020110613084152300_ocaa066-B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.19.00033","article-title":"Conceptual framework to support clinical trial optimization and end-to-end enrollment workflow","author":"Jain","year":"2019","journal-title":"JCO Clin Cancer Inform"},{"key":"2020110613084152300_ocaa066-B39","year":"2019"}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/27\/7\/1057\/34152853\/ocaa066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/27\/7\/1057\/34152853\/ocaa066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T19:22:06Z","timestamp":1604690526000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article\/27\/7\/1057\/5850087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,6,1]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jamia\/ocaa066","relation":{},"ISSN":["1527-974X"],"issn-type":[{"value":"1527-974X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,6,1]]}}}